Optimisation of an enzymatic method for β-galactosidase

Clinica Chimica Acta

Volumn 326, Issue 1-2, 2002, Pages 123-129

  McGuire, James B J ^a   James, Tim J ^a   Imber, Charles J ^a   St Peter, Shawn D ^a   Friend, Peter J ^a   Taylor, Richard P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

galactosidase; Liver; Marker; Perfusion; Preservation; Transplantation

Indexed keywords

BETA GALACTOSIDASE; SODIUM HYDROXIDE; 2 NITROPHENYLGALACTOSIDE; 2-NITROPHENYLGALACTOSIDE; 4 NITROPHENYLGALACTOSIDE; BUFFER; CITRIC ACID; HYMECROMONE; PHOSPHATE;

ARTICLE; ENZYME SUBSTRATE; FLUOROMETRY; INCUBATION TIME; MICROTITER PLATE ASSAY; PH; PRIORITY JOURNAL; REACTION OPTIMIZATION; STATISTICAL ANALYSIS; WAVEFORM; ANIMAL; BIOLOGICAL MODEL; BLOOD; CALIBRATION; CHEMISTRY; ENZYMOLOGY; HUMAN; KINETICS; LIVER; LIVER DISEASE; LIVER TRANSPLANTATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SWINE;

SUIDAE;

ANIMALS; BETA-GALACTOSIDASE; BUFFERS; CALIBRATION; CITRATES; FLUOROMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; HYMECROMONE; KINETICS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; NITROPHENYLGALACTOSIDES; PHOSPHATES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 0036889902     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00332-7     Document Type: Article

References (11)

1. Prince M.I., Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad. Med. J. 78:2002;135-141.
2. Liu W., Schob O., Pugmire J.E., Jackson D., Zucker K.A., Fry D.E.et al. Glycohydrolases as markers of hepatic ischemia-reperfusion injury and recovery. Hepatology. 24:1996;157-162.
3. Clavien P.A., Harvey P.R., Strasberg S.M. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 53:1992;957-978.
4. Jackson D.W., Carder E.A., Voss C.M., Fry D.E., Glew R.H. Altered urinary excretion of lysosomal hydrolases in pregnancy. Am. J. Kidney Dis. 22:1993;649-655.
5. St. Peter S.D., Imber C.J., De Cenarruzabeitia I.L., McGuire J., James T., Taylor R.et al. Beta-galactosidase as a marker of ischemic injury and a mechanism for viability assessment in porcine liver transplantation. Liver Transpl. 8:2002;21-26.
6. St. Peter S.D., Imber C.J., Lopez I., McGuire J., James T., Taylor R.et al. Beta-galactosidase as a novel marker of ischaemic injury and a mechanism for viability assessment in liver transplantation. Transplant. Proc. 33:2001;3753-3755.
7. St. Peter S.D., Imber C.J., Friend P.J. Liver and kidney preservation by perfusion. Lancet. 359:2002;604-613.
8. Dixon M., Webb E. Enzymes. 3rd Ed. 1979;Longman, London.
9. Imber C.J., St. Peter S.D., Lopez de Cenarruzabeitia I., Pigott D., James T., Taylor R.et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation. 73:2002;701-709.
10. Gee K.R., Sun W.C., Bhalgat M.K., Upson R.H., Klaubert D.H., Latham K.A.et al. Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and beta-galactosidases. Anal. Biochem. 273:1999;41-48.
11. Chang C.W., Imai K., Chang Y.C., Hayashi T., Kohno H., Nagasue N.et al. Plasma lysosomal enzymes after liver transplantation in the pig. Enzyme. 45:1991;145-154.